Diet pills have had a chequered history and only one is approved for NHS use in the UK - Xenical - which is not hugely ...

I am concerned the mad scramble to get hold of weight-loss jabs has led to a Wild West market, where it's easy to buy these ...

Dementia, including Alzheimer’s disease and related disorders, is one of the fastest-growing public health concerns globally. It currently affects over 55 million people and is expected to impact 139 ...

Roche's strong U.S. presence and diversified product portfolio may mitigate the impact of potential tariffs, making it a ...

As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are ...

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

Kapil Sharma stunned fans with his noticeably slimmer look at the Mumbai airport, sparking weight loss speculations. While some linked his transformation to intense workouts, others guessed the use of ...

Physicians are turning to other options, including older, cheaper medications, as compounding GLP-1s comes to an end.

A new paper by the Institute for Clinical and Economic Review (ICER) looks at the cost-effectiveness versus affordability ...

About half of Americans "strongly" or "somewhat" favor having Medicare and Medicaid cover weight-loss drugs for people who ...

GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.

Drugs originally developed to treat type 2 diabetes, particularly GLP-1 receptor agonists such as semaglutide (sold as ...